Here we investigate the effects of exogenous administration of FGF21 to obese and insulin-resistant NZO mice, and evaluate the potential of the diabetes-susceptible NZO mouse as an animal model to study endogenous FGF21 actions in regard to the prevention of diabetes in the future. The gene discussed is FGF21; the disease is diabetes mellitus.